Purple Biotech Statistics

Total Valuation

Purple Biotech has a market cap or net worth of ILS 17.20 million. The enterprise value is -5.19 million.

Market Cap	17.20M
Enterprise Value	-5.19M

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Purple Biotech has 365.87 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	365.87M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.65%
Owned by Institutions (%)	0.77%
Float	319.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.12
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.01.

Current Ratio	1.27
Quick Ratio	1.15
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-48.80

Financial Efficiency

Return on equity (ROE) is -34.39% and return on invested capital (ROIC) is -29.18%.

Return on Equity (ROE)	-34.39%
Return on Assets (ROA)	-24.97%
Return on Capital (ROIC)	-29.18%
Revenue Per Employee	n/a
Profits Per Employee	-2.17M
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.85% in the last 52 weeks. The beta is 0.29, so Purple Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.29
52-Week Price Change	-87.85%
50-Day Moving Average	8.65
200-Day Moving Average	19.36
Relative Strength Index (RSI)	15.57
Average Volume (20 Days)	1,252,335

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-728,591
Operating Income	-59.68M
Pretax Income	-43.58M
Net Income	-43.34M
EBITDA	-59.52M
EBIT	-59.68M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 23.42 million in cash and 825,241 in debt, giving a net cash position of 22.59 million or 0.06 per share.

Cash & Cash Equivalents	23.42M
Total Debt	825,241
Net Cash	22.59M
Net Cash Per Share	0.06
Equity (Book Value)	109.54M
Book Value Per Share	n/a
Working Capital	5.50M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-64.44M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Purple Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

The last stock split was on January 6, 2019. It was a reverse split with a ratio of 0.05.

Last Split Date	Jan 6, 2019
Split Type	Reverse
Split Ratio	0.05

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a